Skip to main content

Table 2 Correlation of sST2 with metabolic parameters before and after surgery in the entire cohort

From: The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery

 

sST2 before surgery

sST2 after surgery

r value

P value

r value

P value

Total cholesterol

0.44

< 0.0001

< 0.3

n.s.

Triglyceride

0.42

< 0.0001

< 0.3

n.s.

Total LDL

0.36

0.001

< 0.3

n.s.

Small dense LDL

0.38

0.0006

< 0.3

n.s.

Apolipoprotein B

0.44

< 0.0001

< 0.3

n.s.

Small dense HDL

0.35

0.002

< 0.3

n.s.

Total HDL

< 0.3

n.s.

< 0.3

n.s.

Apolipoprotein A1

< 0.3

n.s.

< 0.3

n.s.

GPT

0.41

0.0002

0.42

0.0008

GOT

0.33

0.003

0.44

0.0005

GGT

0.38

0.0006

0.47

0.0001

Leptin

− 0.31

0.006

− 0.34

0.006

Glucose

< 0.3

n.s.

< 0.3

n.s.

HbA1c

< 0.3

n.s.

  

BMI

< 0.3

n.s.

< 0.3

n.s.

Weight

< 0.3

n.s.

< 0.3

n.s.

Waist circumference

< 0.3

n.s.

< 0.3

n.s.

hsCRP

< 0.3

n.s.

< 0.3

n.s.

hsIL-6

< 0.3

n.s.

0.32

0.01

  1. LDL low density lipoproteins, HDL high density lipoproteins, GPT alanin-aminotransferase, GOT aspartat-aminotransferase, GGT gamma-glutamyl-transferase, HbA1c glycated hemoglobin, BMI body mass index, hsCRP high-sensitive C-reactive protein, hsIL-6 high-sensitive interleukin-6
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840